Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and β-1,3-D-glucan

Hepatology

Volumn 27, Issue 5, 1998, Pages 1241-1248

  Sveinbjørnsson, Baldur ^a   Rushfeldt, Christian ^a   Seljelid, Rolf ^a   Smedsrød, Bård ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIVER METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA-GLUCANS; CARCINOMA; COLONIC NEOPLASMS; DRUG SYNERGISM; FEMALE; GLUCANS; INTERFERON-GAMMA, RECOMBINANT; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM METASTASIS;

EID: 0031960352     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270509     Document Type: Article

References (17)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. Ca-A Cancer. J Clin 1990;40:9-26.
2. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastases. Cancer Metastasis Rev 1984;3:303-324.
3. Lise M, Da Pian PP, Nitti D, Pilati PL, Prevaldi C. Colorectal metastases to the liver: present status of management. Dis Colon Rectum 1990;33:688-694.
4. Seljelid R, Bøgwald J, Hoffman J, Larm OA. A soluble β-1,3-D-glucan derivative potentiates the cytostatic and cytolytic capacity of mouse peritoneal macrophages in vitro. Immunopharmacology 1984;7:69-73.
5. Seljelid R. A water soluble β-1,3-D-glucan derivative causes regression of solid tumors in mice. Biosci Rep 1986;6:845-851
6. Morikawa K, Takeda R, Yamazaki M, Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res 1985;45:1496-1501.
7. Di Renzo L, Yefenof E, Klein E. The function of human NK cells is enhanced by β-glucan, a ligand of CR3 (CD11/CD18). Eur J Immunol 1991;21:1755-1758.
8. Tani M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tamai M, Noguchi K, et al. In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. Eur J Clin Pharmacol 1992;42:623-627.
9. Vetvicka V, Thornton BP, Ross GD. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement type 3 (CD11/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 1996;98:50-61.
10. Williams JG, Jurkovich GJ, Maier RV. Current research review. Interferon-γ: a key immunoregulatory lymphokine. J Surg Res 1993;54:79-93.
11. Sveinbjørnsson B, Olsen R, Seternes OM, Seljelid R. Macrophage cytotoxicity against murine Meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem Biophys Res Commun 1996;223:643-649.
12. 125l-tyraminyl cellobiose. Immunopharmacology 1991;21:149-158.
13. Bøgwald J, Hoffman J, Seljelid R. Coupling of polysaccharides activated by means of chloroacetaldehyde dimethyl acetal to amines or proteins by reductive amination. Carbohydr Res 1986;148:101-107.
14. Smedsrød B. Targeting of polyglucose immunomodulator to liver sinusoidal cells. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the Hepatic Sinusoid. Vol. 3. Leiden, the Netherlands: The Kupffer Cell Foundation 1991:494-496.
15. Corbett TH, Griswold DP, Roberts BJ, Peckham JC, Schabel FM. Tumor induction relationship in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 1975;35:2434-2439.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55-63.
17. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 1995;55:3123-3131.